S&P 500
(0.12%) 5 303.27 points

Dow Jones
(0.34%) 40 004 points

Nasdaq
(-0.07%) 16 686 points

Oil
(0.19%) $80.21

Gas
(1.49%) $2.67

Gold
(0.69%) $2 434.20

Silver
(3.84%) $32.46

Platinum
(0.96%) $1 100.50

USD/EUR
(-0.03%) $0.920

USD/NOK
(-0.09%) $10.67

USD/GBP
(0.02%) $0.787

USD/RUB
(0.09%) $91.05

Realtime updates for Coloplast A/S [CBHD.DE]

Exchange: XETRA Industry: Health Care Equipment & Services

Last Updated17 May 2024 @ 11:35

25% discount on Stockinvest.us - Use code: Podcast

0.80% € 113.50

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 11:35):

Coloplast A/S develops, manufactures, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature...

Stats
Today's Volume	153.00
Average Volume	344.00
Market Cap	25.44B
EPS	€0 ( 2024-05-07 )
Last Dividend	€5.00 ( 2023-05-15 )
Next Dividend	€0 ( N/A )
P/E	37.71
ATR14	€0 (0.00%)

Coloplast A/S Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Coloplast A/S Financials

Annual	2023
Revenue:	€24.50B
Gross Profit:	€16.33B (66.64 %)
EPS:	€22.21

FY	2023
Revenue:	€24.50B
Gross Profit:	€16.33B (66.64 %)
EPS:	€22.21

FY	2022
Revenue:	€22.58B
Gross Profit:	€15.53B (68.78 %)
EPS:	€22.14

FY	2021
Revenue:	€19.43B
Gross Profit:	€13.31B (68.53 %)
EPS:	€22.70

Financial Reports:

No articles found.

Coloplast A/S Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€15.00 (N/A)	€0 (N/A)	€5.00 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Coloplast A/S Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 7.01 - good (70.12%) | Divividend Growth Potential Score: 4.94 - Stable (1.14%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€1.800	2007-12-19
Last Dividend	€5.00	2023-05-15
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	27	--
Total Paid Out	€171.20	--
Avg. Dividend % Per Year	0.00%	--
Score	3.06	--
Div. Sustainability Score	7.01
Div.Growth Potential Score	4.94
Div. Directional Score	5.98	--

Next Divdend (Est)
(2024-07-12)

€4.49 Estimate 3.50 %

Dividend Stability

0.28 Very Poor

Dividend Score

3.06

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
CTP2.DE	Ex Dividend Knight	2023-10-03	Quarterly	0	0.00%
ORC.DE	Ex Dividend Knight	2023-10-11	Quarterly	0	0.00%
FIE.DE	Ex Dividend Junior	2023-07-14	Annually	0	0.00%
SLL.DE	Ex Dividend Knight	2023-05-23	Sporadic	0	0.00%
68V.DE	Ex Dividend Knight	2023-08-07	Quarterly	0	0.00%
I93.F	Ex Dividend Junior	2023-08-28	Quarterly	0	0.00%
VH2.F	Ex Dividend Junior	2023-06-02	Annually	0	0.00%
AWC.DE	Ex Dividend Knight	2023-08-07	Quarterly	0	0.00%
LUS1.DE	Ex Dividend Junior	2023-06-23	Annually	0	0.00%
CIS.DE	Ex Dividend Knight	2023-10-03	Quarterly	0	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.195	1.500	6.11	9.16	[0 - 0.5]
returnOnAssetsTTM	0.103	1.200	6.56	7.87	[0 - 0.3]
returnOnEquityTTM	0.360	1.500	7.11	10.00	[0.1 - 1]
payoutRatioTTM	0.938	-1.000	0.620	-0.620	[0 - 1]
currentRatioTTM	0.600	0.800	-1.998	-1.598	[1 - 3]
quickRatioTTM	0.320	0.800	-2.83	-2.26	[0.8 - 2.5]
cashRatioTTM	0.0514	1.500	-0.826	-1.239	[0.2 - 2]
debtRatioTTM	0.509	-1.500	1.515	-2.27	[0 - 0.6]
interestCoverageTTM	9.92	1.000	7.44	7.44	[3 - 30]
operatingCashFlowPerShareTTM	10.14	2.00	6.62	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.69	2.00	7.66	10.00	[0 - 20]
debtEquityRatioTTM	1.513	-1.500	3.95	-5.92	[0 - 2.5]
grossProfitMarginTTM	0.671	1.000	2.14	2.14	[0.2 - 0.8]
operatingProfitMarginTTM	0.273	1.000	6.54	6.54	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0929	1.000	-0.595	-0.595	[0.2 - 2]
assetTurnoverTTM	0.530	0.800	9.80	7.84	[0.5 - 2]
Total Score				7.01

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	38.32	1.000	6.23	0	[1 - 100]
returnOnEquityTTM	0.360	2.50	8.14	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.69	2.00	8.44	10.00	[0 - 30]
dividendYielPercentageTTM	0.332	1.500	1.691	0	[0 - 0.4]
operatingCashFlowPerShareTTM	10.14	2.00	6.62	10.00	[0 - 30]
payoutRatioTTM	0.938	1.500	0.620	-0.620	[0 - 1]
pegRatioTTM	0.625	1.500	9.17	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0892	1.000	-0.269	0	[0.1 - 0.5]
Total Score				4.94

Coloplast A/S Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Coloplast A/S

Coloplast A/S develops, manufactures, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.